Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Emtnester isn't this the first PTO rejection of the 336?

Yes it is the first one, that I can see.

As far as being expected, after the second OA on 148 I sure expected one. Plus once a reexam is authorized it usually gets at least on non-final rejection...or otherwise the original examiner, who handled the original request, would have denied the request for reexam if there wasn't something that effected the patent.

JMHO

Share
New Message
Please login to post a reply